Background illustration for clinical trials search

Triple Negative Breast Cancer Clinical Trials

Browse 2,256 triple negative breast cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Community-led Navigation to Address Disparities in Mammography Among Native American Women

for
Breast Cancer
Location: Chinle AZ
Sponsor: Johns Hopkins Bloomberg School of Public Health

Sex: Female

Age: 40 - 70+

Code: NCT06957535

Recruiting

Guided Meditation During Radiation Therapy for Breast and Gynecological Malignancies

for
Breast Cancer, Gynecologic Cancer
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: All

Age: 18+

Code: NCT07166042

Phase 3, Recruiting

Adaptive Therapy With Capecitabine for Treatment of Metastatic ER Positive, HER2 Negative Breast Cancer

for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Scottsdale AZ
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06525766

Phase 2, Recruiting

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

for
Advanced/Metastatic Solid Tumors, Bladder Cancer,
Location: Boston MA, Newton MA, New Haven CT, Trumbull CT,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07090499

Phase 1, Recruiting

Development of Patient Derived Xenografts (PDX) in Patients With Breast Cancer

for
Breast Cancer, Residual
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT04703244

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Novel Molecular Approach to Blood DNA Screening for Cancer: Specificity Assessment (The NOMAD Study)

for
Hematopoietic and Lymphoid System Neoplasm,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06192875

Recruiting

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

for
Non Small Cell Lung Cancer, Glioma Glioblastoma Multiforme,
Location: Boston MA, New York NY, Washington D.C. DC, Fairfax VA,
Sponsor: Tango Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06810544

Phase 1, Phase 2, Recruiting

TLN-372 in Advanced KRAS Mutant Solid Tumors

for
KRAS Mutant Solid Tumors
Location: Boston MA, New York NY, Toronto, Grand Rapids MI,
Sponsor: Treeline Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT07204340

Phase 1, Recruiting

Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ

for
DCIS, Breast Cancer, Breast Neoplasms, Sentinel Lymph Node
Location: Houston TX
Sponsor: Uppsala University

Sex: Female

Age: 18+

Code: NCT04722692

Phase 3, Recruiting

Radiation After No Axillary Nodal Sampling

for
Early-stage Breast Cancer,
Location: New York NY
Sponsor: NYU Langone Health

Sex: Female

Age: 40+

Code: NCT07723209

Recruiting

Validation of DNA Methylation Markers for Universal and Site-specific Guided Cancer Detection, VANGUARD Study

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06304168

Recruiting

Olutasidenib Combined With Co-targeted Therapy in Relapsed or Refractory IDH1-mutated Myeloid Malignancies Harboring Activated Signaling Pathway Mutations

for
Targeted Therapy, IDH1-Mutated Malignancies, Mutations
Location: Miami FL, Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07032727

Phase 2, Recruiting

Testing a Brief Motivational Intervention to Increase Physical Activity for Cancer Survivors

for
Cancer
Location: Stony Brook NY
Sponsor: Stony Brook University

Sex: All

Age: 0+

Code: NCT07215091

Recruiting

Effects of KSM-66 Ashwagandha® (300 mg) on Skin and Hair Health in Healthy Men and Women"

for
Skin Health, Hair Health
Location: San Francisco CA
Sponsor: SF Research Institute, Inc.

Sex: All

Age: 18 - 60

Code: NCT07215689

Recruiting

Multi-Cancer Detection Observational Cohort Study

for
Cancer
Location: Jacksonville FL, Rochester MN, Scottsdale AZ
Sponsor: Mayo Clinic

Sex: All

Age: 21+

Code: NCT06962995

Recruiting

UCF MammoChat: Image Repository

for
Breast Cancer, Breast Cancer Awareness, Breast Cancer Detection,
Location: Orlando FL
Sponsor: University of Central Florida

Sex: All

Age: 18+

Code: NCT07214883

Recruiting

A Study of Questionnaires in Adolescents and Young Adults With Cancer

for
Adolescents and Young Adults With Cancer
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 15 - 39

Code: NCT07212166

Recruiting

Personalized Prone Immobilization for Accelerated Partial Breast Radiotherapy

for
Invasive Breast Cancer Early Stages,
Location: New York NY
Sponsor: HeroSupport SA

Sex: Female

Age: 40+

Code: NCT07711847

Recruiting

Testing a Mammography Decision Intervention in a Rural Setting

for
Breast Cancer
Location: New London NH, Keene NH, Newport NH
Sponsor: Dartmouth-Hitchcock Medical Center

Sex: Female

Age: 39 - 49

Code: NCT06522568

Recruiting

A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study

for
Ovarian Neoplasms, Breast Neoplasms
Location: Boston MA, Lake Success NY, Morristown NJ, Toronto,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT04641247

Phase 2, Recruiting

What is triple negative breast cancer?

Triple negative breast cancer, or TNBC, is breast cancer whose cells test negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so hormone therapy and HER2 targeted drugs do not work against it. It tends to grow faster and is more common in women who have not gone through menopause, in Black women, and in people with an inherited BRCA1 mutation, so genetic testing is recommended for everyone diagnosed. In US data, five year relative survival is about 92 percent when it is found while localized, 67 percent with regional spread, and 15 percent once it has reached distant organs. Standard treatment for early stage disease is chemotherapy combined with immunotherapy before surgery, followed by more treatment after; metastatic disease is treated with chemotherapy, immunotherapy for PD-L1 positive tumors, and antibody drug conjugates. Other breast cancers are covered on our breast cancer clinical trials page.

Types of triple negative breast cancer clinical trials

Who can participate in triple negative breast cancer clinical trials?

Is triple negative breast cancer hereditary?

Stages of triple negative breast cancer, and why they matter for trials

How to enroll in a triple negative breast cancer clinical trial